Search Results - "Papadaki, T."

Refine Results
  1. 1

    Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria by Matutes, E, Oscier, D, Montalban, C, Berger, F, Callet-Bauchu, E, Dogan, A, Felman, P, Franco, V, Iannitto, E, Mollejo, M, Papadaki, T, Remstein, E D, Salar, A, Solé, F, Stamatopoulos, K, Thieblemont, C, Traverse-Glehen, A, Wotherspoon, A, Coiffier, B, Piris, M A

    Published in Leukemia (01-03-2008)
    “…Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation by Dagklis, A, Ponzoni, M, Govi, S, Cangi, M G, Pasini, E, Charlotte, F, Vino, A, Doglioni, C, Davì, F, Lossos, I S, Ntountas, I, Papadaki, T, Dolcetti, R, Ferreri, A J M, Stamatopoulos, K, Ghia, P

    Published in Leukemia (01-04-2012)
    “…Evidence from certain geographical areas links lymphomas of the ocular adnexa marginal zone B-cell lymphomas (OAMZL) with Chlamydophila psittaci (Cp)…”
    Get full text
    Journal Article
  5. 5
  6. 6

    PUVA plus interferon alpha 2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series by Nikolaou, V, Siakantaris, M P, Vassilakopoulos, T P, Papadavid, E, Stratigos, A, Economidi, A, Marinos, L, Papadaki, T, Antoniou, C

    “…Background The combination of PUVA with variable doses of systemically administered interferon alpha 2b (IFN- alpha 2b) reduces the number of PUVA treatments…”
    Get full text
    Journal Article
  7. 7
  8. 8

    PUVA plus interferon α2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series by Nikolaou, V, Siakantaris, MP, Vassilakopoulos, TP, Papadavid, E, Stratigos, A, Economidi, A, Marinos, L, Papadaki, T, Antoniou, C

    “…Background  The combination of PUVA with variable doses of systemically administered interferon α2b (IFN‐α2b) reduces the number of PUVA treatments and the…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Anti-CD20-based therapy of B cell lymphoma: state of the art by Kosmas, C, Stamatopoulos, K, Stavroyianni, N, Tsavaris, N, Papadaki, T

    Published in Leukemia (01-10-2002)
    “…Over the last 5 years, studies applying the chimeric anti-CD20 MAb have renewed enthusiasm and triggered world-wide application of anti-CD20 MAb-based…”
    Get full text
    Journal Article
  12. 12

    Activated T‐lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia by Papadaki, H. A., Stamatopoulos, K., Damianaki, A., Gemetzi, C., Anagnostopoulos, A., Papadaki, T., Eliopoulos, A. G., Eliopoulos, G. D.

    Published in British journal of haematology (01-03-2005)
    “…Summary To characterize the cellular components responsible for the impaired granulopoiesis in chronic idiopathic neutropenia (CIN), we investigated the origin…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases by Papadaki, T., Stamatopoulos, K., Stavroyianni, N., Paterakis, G., Phisphis, M., Stefanoudaki-Sofianatou, K.

    Published in Leukemia research (01-06-2002)
    “…We report two cases with B cell malignancies (case #1: refractory mantle cell lymphoma; case #2: lymphocyte predominant Hodgkin’s disease (LPHD)) who developed…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Safety and efficacy of intravitreal triamcinolone acetonide for uveitis macular edema by Androudi, S., Letko, E., Meniconi, M., Papadaki, T., Ahmed, M., Foster, C.S.

    Published in American journal of ophthalmology (01-09-2005)
    “…A retrospective study was performed to evaluate the use of intravitreal triamcinolone acetonide (TA) for treating chronic cystoid macular edema (CME) secondary…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Graft-versus-myeloma after donor leukocyte infusion : maintenance of marrow remission but extramedullary relapse with plasmacytomas by ZOMAS, A, STEFANOUDAKI, K, FISFIS, M, PAPADAKI, T, MEHTA, J

    Published in Bone marrow transplantation (Basingstoke) (01-06-1998)
    “…Adoptive immunotherapy with donor leukocytes has emerged as a promising strategy for the treatment of myeloma recurrence after allogeneic transplantation. 2.9…”
    Get full text
    Journal Article
  20. 20

    Somatic hypermutation targeting to intrinsic hotspots of immunoglobulin genes in follicular lymphoma and multiple myeloma by BELESSI, C, STAMATOPOULOS, K, STAVROYIANNI, N, ZOI, K, PAPADAKI, T, KOSMAS, C

    Published in Leukemia (01-11-2001)
    “…In this study, we analyzed the targeting of the somatic hypermutation (SHM) mechanism at specific hotspot sequence motifs in the V(H) and Vkappa genes of 10…”
    Get full text
    Journal Article